Supplementary Material for: LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 PathwayYuzhang Wu, Ning Zhou, Can J. et al.|Figshare|2021Cited by 0